Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-20

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for methylphenidate hydrochloride (generic). This approval supports the availability of a gener…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE (METHYLPHENIDATE HYDROCHLORIDE)